Results 1 to 10 of about 2,600,404 (289)
Clinical Evolution, Outcomes, and Emerging Preservation Technologies in Pancreas and Islet Transplantation. [PDF]
J Clin MedBellini MI, Papalois V.
europepmc +1 more source
ESA-induced pure red cell aplasia presenting as a precipitous hemoglobin drop in end-stage renal disease. [PDF]
Arch Clin CasesMui JSK.
europepmc +1 more source
Telomere biology disorders in childhood interstitial lung disease: from genetic diagnosis to bedside suspicion - A commentary on "Telomere biology disorders associated with childhood interstitial lung disease". [PDF]
Clin Exp PediatrLilitwat W.
europepmc +1 more source
Tongue Carcinoma in Immunosuppressed Patients After Liver and Kidney Transplantation: A Case Series. [PDF]
Ann TransplantHocková B +7 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Surgical Clinics of North America, 1999
Although several new immunosuppressive medications have been developed in the past decade, many possible avenues are yet to be explored. Although the newer agents have not reflected any clear benefit in patient or graft survival over CsA or tacrolimus, they have been useful in reducing the incidence and severity of rejection, reducing the concomitant ...
A, Jain +4 more
openaire +2 more sources
Although several new immunosuppressive medications have been developed in the past decade, many possible avenues are yet to be explored. Although the newer agents have not reflected any clear benefit in patient or graft survival over CsA or tacrolimus, they have been useful in reducing the incidence and severity of rejection, reducing the concomitant ...
A, Jain +4 more
openaire +2 more sources
Immunosuppressive drug therapy
Current Opinion in Rheumatology, 1994Interstitial lung disease frequently complicates rheumatic disorders, especially polymyositis-dermatomyositis, rheumatoid arthritis, systemic sclerosis, and mixed connective tissue disease. In this article, we review the current data supporting the use of azathioprine, cyclophosphamide, chlorambucil, cyclosporine, and methotrexate in the management of ...
W J, McCune, D K, Vallance, J P, Lynch
openaire +2 more sources
Immunosuppressive therapy and the skeleton
Trends in Endocrinology & Metabolism, 1994Glucocorticoids and other immunosuppressive drugs, such as cytoclosporine A, are increasingly used today. One of the most common clinical situations in which they are prescribed is for immunosuppression after organ transplantation. These drugs have diverse effects on the skeleton, however, and one of the most common sequelae of organ transplantation is
E, Shane, S, Epstein
openaire +2 more sources
Current Opinion in Immunology, 1992
Although Cyclosporin A has improved transplant outcome, its use has serious limitations due to its narrow therapeutic window. New approaches to broaden this window exploit alternative drug formulations, pharmacokinetic profiling and new immunosuppressive agents, such as Rapamycin and Brequinar, which act in a synergistic fashion.
openaire +2 more sources
Although Cyclosporin A has improved transplant outcome, its use has serious limitations due to its narrow therapeutic window. New approaches to broaden this window exploit alternative drug formulations, pharmacokinetic profiling and new immunosuppressive agents, such as Rapamycin and Brequinar, which act in a synergistic fashion.
openaire +2 more sources